Please provide your email address to receive an email when new articles are posted on . Stereotactic ablative body radiotherapy provided 100% disease control for 3 years. Only one patient required ...

Stereotactic body radiotherapy (SBRT) delivers very high doses of radiation with sub-millimetre precision to extracranial metastatic lesions, typically in one to five fractions. In the oligometastatic ...

For patients with intermediate or lower high-risk prostate cancer, side effects are similar with two- or five-fraction ...

Neoadjuvant immunotherapy with ipilimumab plus nivolumab and radiologically and pathologically quantifiable responses through modulation of the tumour microenvironment in resectable hepatocellular ...

Treating breast cancer that has begun to spread around the body with targeted radiotherapy could help patients to live longer ...

SBRT involves constructing very compact high-dose volumes in and about the tumor. Tumor position must be accurately assessed throughout treatment, especially for tumors that move with respiration.

A recent retrospective study found that pancreatic stereotactic body radiotherapy (SBRT) was associated with a low 90-day mortality rate, but early hospitalizations and adverse events, including ...

SBRT combined with Nexavar improved median OS to 15.8 months versus 12.3 months with Nexavar alone in patients with advanced HCC. Median PFS increased from 5.5 months with Nexavar alone to 9.2 months ...